Skip to main content

Market Overview

Why Aurora Cannabis, Cronos And Tilray Are Trading Higher Today

Share:
Why Aurora Cannabis, Cronos And Tilray Are Trading Higher Today

The shares of several cannabis companies are trading higher on Wednesday following the announcement of the Jazz Pharma deal for GW Pharma.

GW Pharma was one of the first pharma companies to use cannabinoids for medical therapy.

Aurora Cannabis (NYSE: ACB) cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71.

See also: How to Invest in Cannabis Stocks

Aurora Cannabis shares were trading up 10.31% at $14.01. The stock has a 52-week high of $26.40 and a 52-week low of $3.71.

Tilray (NASDAQ: TLRY) sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest.

See also: How to Buy Aurora (ACB) Stock

Tilray's stock was up 19.63% at $28.10. The stock has a 52-week high of $28.86 and a 52-week low of $2.43.

Cronos Group Inc (NASDAQ: CRON) cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach.

Cronos stock was up 10.93% at $12.59. The stock has a 52-week high of $12.75 and a 52-week low of $4.

See also: How to Buy Canopy Growth (CGC) Stock

 

Related Articles (ACB + CRON)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com